Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
3
×
cancer
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
3
×
national
national blog main
national top stories
new york blog main
new york top stories
nivolumab
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
3
×
wisconsin blog main
wisconsin top stories
abbvie
alexion pharmaceuticals
alzheimer's disease
biogen
biotech ipos
cancer immunotherapy
cell therapy
diagnostics
What
bio
3
×
drug
3
×
roundup
new
advantages
alzheimer’s
annual
approval
assessed
attention
bar
biogen’s
biopharmaceutical
biotech
brings
communities
companies
conference
convo
earlier
esmo
europe
expect
failures
gamble
germany
hosted
investment
littered
market
medco’s
mover
munich
nash
news
patients
payers
physicians
plan
price
Language
unset
Current search:
drug
×
biotech
×
" texas top stories "
×
bio
×
" bristol-myers squibb "
×
medicare
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More